Diagnóstico de la diabetes mellitus tipo 2. Situación epidemiológica, características de los pacientes, factores de riesgo y pronóstico

  1. J. Boris Quiñones Silva 1
  2. A. Bayona Cebada 2
  3. Héctor Francisco Escobar Morreale 3
  4. Lía Nattero Chávez 4
  1. 1 Servicio de Endocrinología y Nutrición, Hospital Universitario Ramón y Cajal, Madrid, España
  2. 2 Servicio de Endocrinología y Nutrición, Hospital Universitario Ramón y Cajal, Madrid, España Unidad de Diabetes, Hospital Universitario Ramón y Cajal, Madrid, España Grupo de Investigación en Diabetes, Obesidad y Reproducción Humana integrado en el CIBER de Diabetes y Enfermedades Metabólicas, Instituto de Salud Carlos III, Madrid, España Facultad de Medicina, Universidad de Alcalá, Alcalá de Henares, Madrid, España
  3. 3 Servicio de Endocrinología y Nutrición, Hospital Universitario Ramón y Cajal, Madrid, España Grupo de Investigación en Diabetes, Obesidad y Reproducción Humana integrado en el CIBER de Diabetes y Enfermedades Metabólicas, Instituto de Salud Carlos III, Madrid, España Facultad de Medicina, Universidad de Alcalá, Alcalá de Henares, Madrid, España
  4. 4 Servicio de Endocrinología y Nutrición, Hospital Universitario Ramón y Cajal, Madrid, España Unidad de Diabetes, Hospital Universitario Ramón y Cajal, Madrid, España Grupo de Investigación en Diabetes, Obesidad y Reproducción Humana integrado en el CIBER de Diabetes y Enfermedades Metabólicas, Instituto de Salud Carlos III, Madrid, España
Mostra les afiliacions +
Revista:
Medicine: Programa de Formación Médica Continuada Acreditado

ISSN: 0304-5412

Any de publicació: 2024

Títol de l'exemplar: Enfermedades endocrinológicas y metabólicas (VII): Diabetes mellitus

Sèrie: 14

Número: 19

Pàgines: 1099-1106

Tipus: Article

DOI: 10.1016/J.MED.2024.10.018 DIALNET GOOGLE SCHOLAR

Altres publicacions en: Medicine: Programa de Formación Médica Continuada Acreditado

Resum

Type 2 diabetes mellitus (DM2) is one of the most prevalent chronic diseases. It accounts for approximately 90% of diabetes cases worldwide. This disease is characterized by insulin resistance and the progressive dysfunction of pancreatic beta cells, resulting in chronic hyperglycemia. In recent decades, the prevalence of DM2 has increased considerably due to changes in lifestyles, population aging, and urbanization. The complications associated with DM2, such as retinopathy, nephropathy, neuropathy, cardiovascular diseases, and lower extremity amputations, are a significant burden in terms of both healthcare and the economy. Intensive control of blood glucose and cardiovascular risk factors is crucial for preventing these complications. Early detection and effective interventions, such as lifestyle changes and pharmacological treatments, are essential in order to reduce the incidence of DM2 and its comorbidities.

Referències bibliogràfiques

  • 1. J. Franch Nadal et al. Epidemiología y control clínico de la diabetes mellitus tipo 2 y sus comorbilidades en España (estudio e-Control). Med Clin (Barc). (2016)
  • 2. M. Mata et al. [The cost of type 2 diabetes in Spain: the CODE-2 study]. Gac Sanit. (2002)
  • 3. M.H. Forouzanfar et al. Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks in 188 countries, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet. (2015)
  • 4. A. Ramachandran et al. Diabetes in Asia. Lancet. (2010)
  • 5. S.H. Ley et al. Prevention and management of type 2 diabetes: dietary components and nutritional strategies. Lancet. (2014)
  • 6. T.J. Roseboom et al. Effects of prenatal exposure to the Dutch famine on adult disease in later life: An overview. Mol Cell Endocrinol. (2001)
  • 7. S. Taheri et al. Effect of intensive lifestyle intervention on bodyweight and glycaemia in early type 2 diabetes (DIADEM-I): an open-label, parallel-group, randomised controlled trial. Lancet Diabetes Endocrinol. (2020)
  • 8. R. Reyes-García et al. Document on a comprehensive approach to type 2 diabetes mellitus. Endocrinol Diabetes Nutr. (2019)
  • 9. World Health Organization. Global report on diabetes. Geneva; 2016. Disponible en:...
  • 10. C.J. Castro-Juárez et al. Epidemiología genética sobre las teorías causales y la patogénesis de la diabetes mellitus tipo 2. Gac Med Mex. (2017)
  • 11. World Health Organization. https://www.who.int/es/news-room/fact-sheets/detail/diabetes. 2023....
  • 12. R.R. Holman et al. 10-year follow-up of intensive glucose control in type 2 diabetes. N Engl J Med. (2008)
  • 13. J.W.Y. Yau et al. Global prevalence and major risk factors of diabetic retinopathy. Diabetes Care. (2012)
  • 14. I. Vinagre et al. Control of glycemia and cardiovascular risk factors in patients with type 2 diabetes in primary care in Catalonia (Spain). Diabetes Care. (2012)
  • 15. Q. Qiao. Age and sex-specific prevalences of diabetes and impaired glucose regulation in 13 European Cohorts. Diabetes Care [Internet]. (2003)
  • 16. F. Soriguer et al. Prevalence of diabetes mellitus and impaired glucose regulation in Spain: The Di@bet.es Study. Diabetologia. (2012)
  • 17. Mañé Serra L, Benaiges Boix D, Goday Arno A. Diabetes mellitus tipo 2. Epidemiología y patogenia. En: Manual de...
  • 18. Committee ADAPP et al. 2. Diagnosis and Classification of Diabetes: Standards of Care in Diabetes-2024. Diabetes Care. (2024)
  • 19. A.S. Meijnikman et al. Not performing an OGTT results in significant underdiagnosis of (pre)diabetes in a high risk adult Caucasian population. Int J Obes (Lond). (2017)
  • 20. E. Selvin et al. Glycated hemoglobin, diabetes, and cardiovascular risk in nondiabetic adults. N Engl J Med. (2010)
  • 21. X. Zhang et al. A1C level and future risk of diabetes: a systematic review. Diabetes Care. (2010)
  • 22. R. Palladino et al. Association between pre-diabetes and microvascular and macrovascular disease in newly diagnosed type 2 diabetes. BMJ Open Diabetes Res Care. (2020)
Fuente de los datos: Dialnet